| Tracer | System | Parameter Measured | Results | Reference |
|---|---|---|---|---|
| GdDTPA (Magnevist) | Bone sarcoma | Permeability | Associations found between expression of VEGF and increases in permeability | [122] |
| GdDTPA (Magnevist) | Head & neck, prostate & brain neoplasms | Rate of uptake, kep | Demonstrated reproducibility of kep | [123] |
| GdDTPA (Magnevist) | Breast tumors | Permeability | Significant change in permeability pre- and post- treatment | [124] |
| Gadodiamide (Gd- DTPA-BMA) | Cerebral glioma | Permeability | Demonstrated reproducibility of permeability | [125] |
| GdDTPA (Magnevist) | Breast tumors | Exchange rates | Significant differentiation between malignant and benign tissue | [126] |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.